G. De Marchi

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

Francesco Zaja, Salvatore De Vita, Cesare Mazzaro et al. · Blood · 2003 · 490 citations · Full text

Medicine, Immunology, Internal Medicine +4

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

Luca Quartuccio, Giorgio Soardo, G. Romano et al. · Lara D. Veeken · 2006 · 183 citations · Full text

Medicine, Immunology, Nephrology +17

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Salvatore De Vita, Franca Soldano, Miriam Isola et al. · Annals of the Rheumatic Diseases · 2011 · 156 citations · Full text

Natural Sciences, Biophysics, Hematology +17

Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study

Luca Quartuccio, Miriam Isola, Chiara Baldini et al. · Journal of Autoimmunity · 2013 · 153 citations

Medicine, Hematology, Internal Medicine +16

Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting

Mariele Gatto, Francesca Saccon, Margherita Zen et al. · Arthritis & Rheumatology · 2020 · 114 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17